Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1

Conditions

Post-traumatic Stress Symptoms 1Ovarian Neoplasms 1Neoplasms 1Frailty 1Endometrial Neoplasms 1Depression 1Anxiety Disorders 1

Interventions

Specimen Handling 613pembrolizumab 583Magnetic Resonance Spectroscopy 543Carboplatin 430Cyclophosphamide 380Cisplatin 377Biopsy 366Paclitaxel 314Nivolumab 312Gemcitabine 308Radiotherapy 268Bevacizumab 230Dexamethasone 217fludarabine 205Docetaxel 190durvalumab 188venetoclax 187Oxaliplatin 187Rituximab 174Fluorouracil 174atezolizumab 169Pemetrexed 166Capecitabine 162Radiosurgery 160Doxorubicin 160Radiation 156Ipilimumab 144Lenalidomide 140Leucovorin 138Etoposide 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Psychosocial Intervention × 90 days × Clear all
NCT07582666 2026-05-13

CAERES

UniDistance Suisse

Phase NA Completed
32 enrolled

Anxiety Disorders, Depression, Neoplasms

NCT07160933 2026-03-31

Development of a Psychosocial Intervention to Reduce Post Traumatic Stress in Young Adult Survivors of Cancer

Massachusetts General Hospital

Phase NA Not yet recruiting
80 enrolled

Post-traumatic Stress Symptoms

NCT04789694 2026-03-19

PHOCUS

Charles University, Czech Republic

Phase 3 Recruiting
64 enrolled
Gynecologic

Frailty, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡